B2B buyers face a critical decision when selecting a collagen raw material. The wrong choice between Type I and Type II directly impacts formulation success, regulatory compliance, and final product cost. This collagen peptide type sourcing guide provides a clear comparison across sourcing, regulatory, quality, and formulation dimensions. The core distinction drives every b2b sourcing decision. Type I is typically hydrolyzed from marine or bovine sources and exists as hydrolyzed collagen peptides. Type II collagen, in contrast, is often undenatured and sourced from chicken sternum cartilage. For buyers requiring type II in a hydrolyzed format, Beyond Biopharma supplies Hydrolyzed Collagen Type II with full batch traceability and complete regulatory support.
Collagen is the most abundant protein in the human body. Type I collagen accounts for roughly 90% of total body collagen. This protein provides structural support for skin, hair, nails, bones, and tendons. Type II collagen concentrates in cartilage and joints. These two proteins serve distinct biological roles. Buyers must understand this difference before selecting a raw material.
Type I collagen is commonly hydrolyzed into peptides for better bioavailability. The hydrolysis process breaks long protein chains into smaller units. These hydrolyzed collagen peptides absorb efficiently through the intestinal wall. Type II collagen is often marketed in undenatured form. This native structure is believed to support joint health through a different mechanism. Hydrolyzed Type II also exists. Beyond Biopharma produces Hydrolyzed Collagen Type II through precision enzymatic hydrolysis. This product offers an alternative for formulators seeking a soluble peptide format.
The human body contains collagen types I, II, III and others. Each type has a unique amino acid sequence and tissue distribution. Type III collagen appears in skin and blood vessels alongside Type I. This overlap matters for product positioning. A formula targeting skin may benefit from Type I, while a joint-focused product may require Type II.
Raw material selection determines product quality and regulatory pathway. Type I comes from bovine or marine raw materials. Bovine sources include hide and bone. Marine sources include fish skin and scales. Each source carries distinct supply chain considerations. Marine collagen offers advantages for pescatarian markets. Bovine collagen provides a well-established supply infrastructure.
Type II collagen derives from chicken sternum cartilage. This tissue is a concentrated natural source of the protein. High-quality manufacturers use byproducts from USDA- or EU-approved facilities. This practice maintains ethical and safety standards. Raw materials are sourced from GMP-verified, food-grade suppliers. This ensures traceability and safety from the start.
The production process for undenatured Type II differs from hydrolyzed manufacturing. Chicken sternum cartilage is the primary raw material for undenatured applications. The process preserves the native structure rather than breaking it into peptides. This is a meaningfully different approach. For hydrolyzed Type II, specific food-grade enzymes break long protein chains into smaller peptides. The process reduces molecular weight to approximately 2–5 kDa. The resulting smaller peptides dissolve easily in water and are more bioavailable.
Quality control testing before shipment includes identity verification through protein fingerprinting. Heavy metals such as Pb, Cd, As, and Hg are tested. Microbial counts including TPC, yeast, mold, E. coli, and Salmonella are monitored. Moisture and solubility are also checked. These steps ensure each batch meets specification.
Type I collagen comes from two primary raw material streams: bovine hide and bone, or fish skin and scales. Each stream carries distinct supply chain dynamics. Bovine sourcing benefits from a mature, year-round infrastructure. Marine sourcing faces more volatility.
The marine collagen industry relies on fish by-products that are seasonal and unpredictable, leading to challenges in consistency, quality, and cost-effectiveness for manufacturers.
The fish collagen peptides market is exposed to seasonal catch patterns and species-specific yield swings, which cause volatility in raw material prices and supply constraints for B2B buyers.
Regulatory changes add another layer of risk. Fishing quotas designed to combat overfishing have reduced fish waste, which limits the production of fish collagen and related goods. This regulatory impact on raw material availability represents a significant supply chain risk for marine collagen peptides.
For bovine collagen, buyers must verify BSE-free certification. Reputable manufacturers source only from BSE-free countries with full traceability. Marine collagen requires species identification testing and heavy metal analyses for mercury and cadmium. The table below summarizes key certification requirements by source.
Source | Collagen Types | Species-Specific Certifications Required | Other Regulatory Considerations |
|---|---|---|---|
Bovine (hide & bone) | Type I, Type III | BSE-free certification required | Country-of-origin traceability; certificates of origin and veterinary health statements |
Marine (fish skin & scales) | Type I | Sustainability certifications (MSC, ASC) | Species identification testing; heavy metal analyses (mercury, cadmium); full traceability from catch/aquaculture origin |
Chicken (sternum cartilage) | Type II | Avian disease-free sourcing | Poultry processing regulations |
For supplying collagen to the EU market, raw materials must satisfy strict sourcing criteria. Traceability requires documented proof of origin, including supplier declarations and veterinary health certificates. Safety compliance mandates that materials be free from contaminants such as heavy metals, microbial pathogens, and prohibited animal materials under EU Regulation 999/2001. These EU sourcing requirements apply equally to bovine and marine streams.
Type II collagen derives from chicken sternum cartilage. This tissue is a concentrated natural source of the protein. Raw materials come from USDA- or EU-approved facilities. Veterinary Health Certification supports every batch. This documentation confirms the raw material meets food-grade safety standards.
Traceability for Type II collagen depends on batch-level records and third-party verification. Buyers should request the following documentation package:
Certificate of Analysis (CoA) for every batch verifying potency, heavy metals, microbial content, and banned substances.
Sourcing transparency documentation covering animal origin, farming practices, and traceability.
Third-party testing on every batch: identity, potency, amino acid profile, microbial, label claim.
Batch record documentation capturing raw material lot numbers, incoming COAs, in-process weights, equipment use and cleaning logs, blend records, packaging and labeling documentation, and third-party test results.
Records are maintained per FDA retention requirements and available for client audits. Facility registration documentation is available upon request. For BSE-free claims, buyers should get specific documentation, not just a general statement. Ask suppliers how they control batch-to-batch consistency. Request molecular weight distribution data across multiple batches. Negotiate consistency specs into the purchase agreement.
A sound b2b sourcing strategy for Type II collagen also includes verifying that active certifications cover the specific product. Request copies of active certifications, not just marketing claims. Confirm the certification scope covers your product. Ask about raw material sourcing and whether it affects certification status.
B2B buyers must understand the regulatory frameworks for both major markets. The collagen regulations in the EU center on Regulation (EU) 2015/2283. Under this rule, collagen peptides may require Novel Food authorization. Specific dossiers are needed. They cover toxicology data, exposure assessment, process validation, and claims strategy. Regulatory readiness must begin early in development. Not every collagen source triggers Novel Food classification though. Egg membrane collagen peptides gained authorization based on compositional data alone. No extra toxicology studies were required. Regulatory considerations differ for each raw material. Buyers should verify Novel Food status for their specific raw material.
For the US market, the FDA classifies hydrolyzed Type II as a dietary ingredient. No pre-market approval exists for supplements. Manufacturers must ensure safety and proper labeling. Certifications simplify supplier verification. Request GMP compliance documentation. Also request ISO 22000 for food safety management. ISO 9001 demonstrates quality management commitment. FSSC 22000 adds verified food safety practices. These certifications reduce audit burden. They also show a supplier commitment to global standards.
Labels must distinguish hydrolyzed from undenatured type II collagen. This distinction matters for consumer understanding. Joint health claims require careful wording. Structure/function claims describe how collagen supports normal joint function. Disease claims require prior FDA approval. The required disclaimer for supplement labels states:
"This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."
Manufacturers must submit structure/function claim notifications to FDA within 30 days of marketing. Regulatory considerations also include EU health claim rules. EFSA evaluates scientific evidence before accepting health claims. Buyers must verify permitted claims for each target market. Claims strategy must match the specific collagen source and product positioning.
For collagen used in food supplements, sourcing documentation matters. Bovine and marine sources require different certificates. Supply chain transparency supports compliance filings. Buyers should request certificates of analysis for every batch. These documents verify identity, purity, and safety. Working with a supplier that provides full documentation reduces regulatory risk. Each peptide type carries distinct regulatory requirements. Proper documentation supports market access in both regions.
Buyers must verify key specifications before approving any collagen raw material. Hydrolyzed Collagen Type II typically contains >60% protein content and at least 25.0% mucopolysaccharides. The pH range sits between 5.5 and 7.5. Molecular weight stays below 5,000 Daltons for optimal absorption. These parameters directly affect collagen product quality and finished supplement performance.
A Certificate of Analysis confirms batch-to-batch consistency. Buyers should review solubility, color, and odor data across multiple batches. Heavy metals and microbial testing are non-negotiable. The table below shows typical heavy metal limits for collagen peptides.
Heavy Metal | Specification (ppm) |
|---|---|
Cadmium | ≤0.10 |
Mercury | ≤0.02 |
Arsenic | ≤0.7 |
Lead | ≤0.50 |
Peptide size influences absorption. Hydrolyzed collagen peptides between 2,000 and 5,000 Daltons represent the optimal size range. Smaller peptides pass through the intestinal barrier more efficiently. This supports gut support and overall bioavailability.
Neutral-flavored powder works across multiple delivery formats. Manufacturers use it in capsules, tablets, and functional foods. The powder dissolves cleanly in cold water. This makes it ideal for collagen drinks and collagen-forward beverages.
Solubility and dispersion matter for collagen drink manufacturing. Hydrolyzed collagen shows low viscosity and neutral odor in solution. These traits support clear beverage applications. Bovine and marine sources both offer suitable options, though marine peptides typically absorb faster.
Standard packaging is 25KG per bag with customization available. This supports efficient production across collagen supplement lines.
Smart formulation pairs each collagen type with complementary nutrients. For bone health products, combine Type II with calcium, magnesium, and vitamin D. This mineral trio supports bone mineral density while collagen peptides provide the organic matrix.
Combining collagen with calcium, vitamin D, and magnesium produces more comprehensive bone support than any single nutrient alone. Clinical trials comparing collagen supplementation to calcium alone indicate that collagen offers additional benefits for bone flexibility, fracture healing, and overall bone quality that minerals cannot achieve independently.
An independent clinical study tracked 51 women over 12 months. One group received collagen plus calcium and vitamin D. The other group received only calcium and vitamin D. Advanced CT scans measured bone changes. The collagen group showed 2–5% improvement in bone density. Trabecular bone and lumbar spine density both improved.
For multi-benefit formulas, combine Type I collagen with Type II. This pairing supports skin, joint, and gut health in one product. Type I collagen addresses skin elasticity and hair strength. Type II targets cartilage and joint comfort. A gut support blend may also include these peptides for connective tissue benefits throughout the body.
Beyond Biopharma brings over 20 years of collagen manufacturing expertise to every partnership. The company uses precision enzymatic hydrolysis to control peptide size and bioactivity. Spray-drying ensures batch-to-batch consistency in solubility, color, and odor. These processes matter for collagen drink manufacturing and capsule production alike.
Buyers should evaluate suppliers using clear performance indicators. Request comprehensive Certificates of Analysis with actual HPLC and MS data. Verify GMP compliance and ISO certification. Confirm batch-by-batch testing with third-party lab reports. Traceability systems from raw material to final product are essential.
Beyond Biopharma offers samples, regulatory documentation, custom peptide profiles, and formulation guidance. The team assists with novel food registration and provides GRAS or FDA documentation. This support simplifies market entry for collagen drinks, capsules, and functional foods. Whether your formula uses bovine or marine sources, the right partner reduces risk and accelerates development.
Every sourcing decision begins with the correct collagen type. Type I and Type II collagen serve different purposes. Select the source — bovine or marine for Type I, chicken for Type II. Match the application to the collagen format. Joint health formulas need Type II. Gut health or skin products benefit from Type I. Review quality documentation and regulatory compliance for your target market. The wrong collagen choice creates formulation problems in collagen supplement development. Verify every peptide specification before purchase. Contact Beyond Biopharma for samples, COAs, and formulation support. Their sourcing expertise simplifies your decision.
Type II collagen concentrates in cartilage and joints. Most joint health products use Type II from chicken sternum cartilage. Hydrolyzed Collagen Type II from Beyond Biopharma offers a soluble peptide format with documented specifications. Formulators pair it with calcium, magnesium, and vitamin D for bone support.
Buyers review the Certificate of Analysis for every batch. Key checks include total protein, mucopolysaccharides, pH, molecular weight, heavy metals, and microbial counts. Request third-party lab reports and batch records. Beyond Biopharma maintains GMP, ISO 22000, ISO 9001, and FSSC 22000 certifications.
Yes. Type I supports skin, hair, and nails. Type II targets cartilage and joint comfort. A combined formula delivers multi-benefit positioning. Buyers may blend bovine or marine Type I with chicken-derived Type II. Each source requires its own documentation package.
Neutral-flavored hydrolyzed collagen powder dissolves cleanly in cold water. Low viscosity and neutral odor support clear beverage applications. The same powder works in capsules, tablets, and functional foods. Standard packaging is 25KG per bag with customization available.
Collagen peptides provide amino acids used in connective tissue throughout the body. Some formulators position them within gut support blends. Buyers should match claims to the specific peptide and target market rules. Structure/function claims require careful wording and FDA notification within 30 days.